Altre lingue GC Biopharma Corp.

Azioni

A006280

KR7006280002

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 12/07/2024			Variaz. 5gg	Var. 1 gen.
126.600 ^KRW	+1,28%		+7,29%	+0,88%

03/07	GC Biopharma si allea con un gestore di benefici farmaceutici statunitense per un trattamento di immunodeficienza	MT
10/06	La FDA concede la designazione Fast Track a GC1130A di GCBP e Novel Pharma	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

GC Biopharma Teams Up with US Pharmacy Benefit Manager for Immunodeficiency Treatment	03/07
FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A	10/06
Gc Biopharma and Novel Pharma Announce Sanfilippo Syndrome Treatment Obtains FDA IND Approval	20/05
GC Biopharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05
Green Cross Widens Q1 Loss, Sales Inch Up 2%	03/05
GC Biopharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
GC Biopharma Corp. Announces US FDA Approval for ALYGLO (Immune Globulin Intravenous, Human-Stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)	18/12
GC Biopharma Establishes mRNA Production Facility in Hwasun, Korea	01/12
GC Biopharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
GC Biopharma Applies for MFDS Approval	06/11
Immetas Therapeutics and GC Biopharma Announces Research Collaboration to Discover and Develop mRNA Therapeutics to Treat Autoimmune Diseases	12/10/23
GC Biopharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Green Cross's Net Income Plunges in Q2	02/08/23
GC Biopharma's "GC FLU" Obtains Vaccine Approval in Egypt	21/07/23
GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent	19/07/23
GC Biopharma Receives a Business License for the Construction of a Plasma Fractionation Plant and Technology Transfer in Indonesia	02/06/23
GC Biopharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Green Cross Swings to Loss in Q1	03/05/23
GC Biopharma Takes Over Catalyst Biosciences' Orphan Hematology Disorder Treatment Candidates	01/03/23
GC Biopharma Receives WHO Pre-Qualification for BARYCELA	20/02/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue GC Biopharma Corp.

Azioni

A006280

KR7006280002

Altre lingue

Filtri